Humana (HUM) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $7.61
- EPS estimate
- $7.26
- EPS surprise
- +4.75%
- Revenue surprise
- +0.74%
- Revenue
- $40.9B
- Revenue estimate
- $40.6B
- Reported
- Jul 29, 2026
Humana reported Q2 2026 results on July 29, 2026. Earnings per share came in at $7.61, ahead of the $7.26 estimate by 4.75%. Revenue was $40.9 billion, above the $40.6 billion consensus by 0.74%. Compared with Q2 2025, EPS rose about 21% from $6.27 and revenue rose about 26% from $32.4 billion.
The longer record shows rising sales and uneven earnings. Annual revenue rose from $92.9 billion in 2022 to $129.6 billion in 2025, about 40% higher. Annual EPS was $25.21 in 2022 and $25.99 in 2023, then $16.19 in 2024 and $17.13 in 2025. Humana posted losses in Q4 2023, Q4 2024 and Q4 2025, the last at $3.96 per share. The high in the table was $11.58 per share in Q1 2025. The first half of 2026 adds up to $17.92, about the same as the $17.85 of the first half of 2025. Over the last 20 quarters, Humana beat the EPS estimate 19 times. The only miss was Q4 2023, a loss against an expected profit.
Humana reported Q3 between October 30 and November 5 in each of the past five years. That points to late October or early November 2026 for the next report.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 29, 2026 | $7.26 | $7.61 | +4.75% | $40.9B | SEC |
| Q1 2026 | Apr 29, 2026 | $10.20 | $10.31 | +1.11% | $39.6B | SEC |
| Q4 2025 | Feb 11, 2026 | −$4.00 | −$3.96 | +1.05% | $32.5B | SEC |
| Q3 2025 | Nov 5, 2025 | $2.93 | $3.24 | +10.73% | $32.6B | SEC |
| Q2 2025 | Jul 30, 2025 | $5.92 | $6.27 | +5.96% | $32.4B | SEC |
| Q1 2025 | Apr 30, 2025 | $10.07 | $11.58 | +14.97% | $32.1B | SEC |
| Q4 2024 | Feb 11, 2025 | −$2.23 | −$2.16 | +3.19% | $29.2B | SEC |
| Q3 2024 | Oct 30, 2024 | $3.42 | $4.16 | +21.68% | $29.4B | SEC |
| Q2 2024 | Jul 31, 2024 | $5.86 | $6.96 | +18.69% | $29.5B | SEC |
| Q1 2024 | Apr 24, 2024 | $6.12 | $7.23 | +18.16% | $29.6B | SEC |
| Q4 2023 | Jan 25, 2024 | $0.81 | −$0.11 | −113.63% | $26.5B | SEC |
| Q3 2023 | Nov 1, 2023 | $7.16 | $7.78 | +8.62% | $26.4B | SEC |
| Q2 2023 | Aug 2, 2023 | $8.76 | $8.94 | +2.08% | $26.7B | SEC |
| Q1 2023 | Apr 26, 2023 | $9.27 | $9.38 | +1.18% | $26.7B | SEC |
| Q4 2022 | Feb 1, 2023 | $1.46 | $1.62 | +10.88% | $22.4B | SEC |
| Q3 2022 | Nov 2, 2022 | $6.28 | $6.88 | +9.62% | $22.8B | SEC |
| Q2 2022 | Jul 27, 2022 | $7.67 | $8.67 | +13.09% | $23.7B | SEC |
| Q1 2022 | Apr 27, 2022 | $6.80 | $8.04 | +18.23% | $24.0B | SEC |
| Q4 2021 | Feb 2, 2022 | $1.16 | $1.24 | +7.16% | $21.1B | SEC |
| Q3 2021 | Nov 3, 2021 | $4.68 | $4.83 | +3.31% | $20.9B | SEC |
Quarterly revenue
Frequently asked questions
When did Humana (HUM) last report earnings?
Humana last reported on Jul 29, 2026, covering fiscal Q2 2026.
Did HUM beat earnings estimates?
Yes. Humana reported EPS of $7.61 for Q2 2026 against a $7.26 estimate — a 4.75% beat.
How much revenue did HUM report last quarter?
Humana reported $40.9B in revenue for Q2 2026, against a consensus estimate of $40.6B.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.